Hangzhou Biotest Biotech Co., Ltd. engages in the research, development, production and sales of point-of-care testing (POCT) diagnostic reagents. Its main products are POCT rapid diagnostic reagent products. Its offers reproductive health testing series, drug abuse (drug) testing series, infectious disease testing series, tumor marker testing series, and myocardial marker testing series. The company was founded on November 28, 2008 and is headquartered in Hangzhou, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company